The largest ever genomic study of pneumonia has identified the genetic risk signals of the disease, paving the way for potential new treatments and the use of precision medicine.
You may also be interested in:
A National Institutes of Health clinical trial has found that a monoclonal antibody, mepolizumab, decreased asthma attacks by 27% in Black and Hispanic children and [...]
It’s not the mobile that makes children hyperactive, but the other way round: a fidgety child will use a mobile phone more—according to the latest [...]
A lifeguard shortage in many parts of the U.S. means an increased drowning risk at pools and beaches this summer. Earlier this summer, SciLine interviewed [...]